Meeting of the IDEA Working Group on the feasibility of a study to assess the effectiveness of QRA

06 Apr

Over 2015, IDEA worked on the development of a revised QRA methodology (QRA2), focusing on total exposure of consumers to individual fragrances. For this purpose, a joint academia/industry IDEA working group has reviewed the uncertainties where a safety assessment factor (SAF) is warranted and the scientific basis for the assignment of each SAF value. Moreover, an aggregate exposure model based on actual consumer use of products which involves the utilization of these SAF values has been developed.

The work that resulted out of this science-based multi-stakeholder dialogue was presented at the IDEA Annual Review 2015 by Prof. Jim Bridges, Chair of the IDEA Supervisory Group, pointing out that the need was identified to now move on the implementation of the revised QRA and evaluate the feasibility to assess the effectiveness via monitoring of clinical data.

A working group met on April 6th, 2016 in Leuven (Belgium) to define the objectives and to initiate the discussion on the protocol of such study.

Related Documents